MX385489B - Composicion oftalmica que comprende pvp-i. - Google Patents

Composicion oftalmica que comprende pvp-i.

Info

Publication number
MX385489B
MX385489B MX2018012311A MX2018012311A MX385489B MX 385489 B MX385489 B MX 385489B MX 2018012311 A MX2018012311 A MX 2018012311A MX 2018012311 A MX2018012311 A MX 2018012311A MX 385489 B MX385489 B MX 385489B
Authority
MX
Mexico
Prior art keywords
ophthalmic composition
oil phase
pvp
includes pvp
composition
Prior art date
Application number
MX2018012311A
Other languages
English (en)
Other versions
MX2018012311A (es
Inventor
Barbara MELILLI
Danilo Aleo
Maria Grazia Saita
Melina Cro
Sergio Mangiafico
Original Assignee
Medivis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivis S R L filed Critical Medivis S R L
Publication of MX2018012311A publication Critical patent/MX2018012311A/es
Publication of MX385489B publication Critical patent/MX385489B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

El objetivo de la presente invención es una composición oftálmica que comprende povidona yodada (PVP-l) a una concentración de entre un 0,2-1,0% (p/p), en la que dicha composición oftálmica tiene una fase acuosa y una fase oleosa, consistiendo dicha fase oleosa en triglicéridos de cadena media y constituyendo dicha fase oleosa menos de un 3% del peso total de dicha composición.
MX2018012311A 2016-04-08 2017-02-17 Composicion oftalmica que comprende pvp-i. MX385489B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUA2016A002425A ITUA20162425A1 (it) 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I
PCT/IB2017/050911 WO2017175075A1 (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising pvp-i

Publications (2)

Publication Number Publication Date
MX2018012311A MX2018012311A (es) 2019-05-22
MX385489B true MX385489B (es) 2025-03-18

Family

ID=56555535

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018012311A MX385489B (es) 2016-04-08 2017-02-17 Composicion oftalmica que comprende pvp-i.

Country Status (14)

Country Link
US (1) US20200000714A1 (es)
EP (1) EP3439631B1 (es)
CN (1) CN108883064B (es)
AU (1) AU2017247694B2 (es)
CA (1) CA3019748C (es)
CL (1) CL2018002861A1 (es)
ES (1) ES2950498T3 (es)
IT (1) ITUA20162425A1 (es)
MA (1) MA44601A (es)
MX (1) MX385489B (es)
PL (1) PL3439631T3 (es)
PT (1) PT3439631T (es)
RU (1) RU2740910C2 (es)
WO (1) WO2017175075A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108451903B (zh) * 2018-07-05 2019-03-22 广东腾骏动物药业股份有限公司 一种聚维酮碘溶液及其制备方法
CA3107304A1 (en) * 2018-07-24 2020-01-30 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
US12472162B2 (en) * 2018-07-24 2025-11-18 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
CN114502205B (zh) * 2019-08-18 2024-08-06 艾威药业公司 含稀聚维酮碘制剂的稳定药品
CN110559175A (zh) * 2019-08-27 2019-12-13 陈文龙 一种结膜囊消毒溶液及其使用方法和装置
EP4100063A1 (en) * 2020-02-03 2022-12-14 Medivis S.r.l. Stable ophthalmic formulations based on low-concentration povidone iodide in plastic containers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000044A1 (fr) * 1987-07-07 1989-01-12 Santen Pharmaceutical Co., Ltd. Larme artificielle
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
JP2011505409A (ja) * 2007-12-04 2011-02-24 ノバガリ ファーマ エスエー パルミチン酸デキサメタゾンのようなコルチコステロイドプロドラッグを含有する眼障害の治療用の組成物
EP2278953B1 (en) * 2008-05-28 2016-05-04 Alcon Research, Ltd Self-preserved emulsions
EP3777536A1 (en) * 2008-06-12 2021-02-17 Takeda Pharmaceutical Company Limited Povidone iodine, a novel alternative preservative for ophthalmic compositions
IT1404931B1 (it) * 2010-06-11 2013-12-09 Medivis S R L Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液

Also Published As

Publication number Publication date
ES2950498T3 (es) 2023-10-10
RU2740910C2 (ru) 2021-01-21
BR112018070734A2 (pt) 2019-02-05
EP3439631A1 (en) 2019-02-13
US20200000714A1 (en) 2020-01-02
AU2017247694B2 (en) 2022-04-21
WO2017175075A1 (en) 2017-10-12
RU2018139074A3 (es) 2020-06-30
CN108883064A (zh) 2018-11-23
EP3439631B1 (en) 2023-05-10
CA3019748C (en) 2024-01-09
AU2017247694A1 (en) 2018-10-25
MA44601A (fr) 2019-02-13
CN108883064B (zh) 2022-09-16
PT3439631T (pt) 2023-07-28
RU2018139074A (ru) 2020-05-12
CA3019748A1 (en) 2017-10-12
CL2018002861A1 (es) 2019-02-22
PL3439631T3 (pl) 2023-09-04
MX2018012311A (es) 2019-05-22
ITUA20162425A1 (it) 2017-10-08

Similar Documents

Publication Publication Date Title
MX385489B (es) Composicion oftalmica que comprende pvp-i.
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
EP3826467A4 (en) PLATFORM FOR THE DEVELOPMENT OF MICROBIAL CONSORTIA INHIBITING PLANT PATHOGENS PRESENT IN THE SOIL
MA54169A (fr) Tolyles substitués utilisés en tant que fongicides
CL2017003089A1 (es) Formas de dosificación sólidas de palbociclib
CR20200274A (es) Oxadiazoles fungicidas
BR112018004620A2 (pt) moduladores da expressão de kras
BR112017006137A2 (pt) formulação que contém biotensoativo
MX383652B (es) Moduladores de la vía de estrés integrada.
MX390655B (es) Derivados de aceite natural maleatado a manera de ingredientes agroquimicos inertes.
MX2021003170A (es) Moduladores de la expresion de pnpla3.
CR20190471A (es) Moduladores de la expresión de pcsk9
EA201890491A1 (ru) Концентраты суспензий на масляной основе с низким гравитационным разделением и низкой вязкостью
MX392791B (es) Composiciones de aceite esencial y aplicaciones que usan aceites esenciales.
HUE063522T2 (hu) Természetes megoldások nyelve
MX380731B (es) Concentrados de emulsión pesticida que contienen aceites naturales o derivados del petróleo y métodos de uso.
BR112018013433A2 (pt) misturas fungicidas sinergísticas para controle de fungos de praga de arroz
EA201990064A1 (ru) Противомалярийные композиции и варианты их применения
MX2017001064A (es) Piridonas como herbicidas.
BR102020023578A8 (pt) Composições e métodos para tratamento do olho
EP3596175A4 (en) NANOPARTICLES FOR THE ADMINISTRATION OF CHEMOPREVENTIVE AGENTS
MX2023008764A (es) Composiciones y metodos para prevenir y tratar afecciones.
MX376853B (es) Odorante osmanthus.
MX2021004581A (es) Composiciones acuosas que comprenden omega nitrooxi-1-alcanoles.